LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NAS: SLP) , a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it ...
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NAS: SLP) , a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods ...
“Our software updates reflect the needs our customers communicate to us, and GastroPlus 9.9 is no exception,” said Neil Miller, Vice President of Simulation Sciences at Simulations Plus. “We ...
EVRY, France--(BUSINESS WIRE)--PhinC Development, a company specialized in early drug development strengthens its offer in pharmacometrics. This new PBPK service (Physiologically Based Pharmacokinetic ...
, a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that the U.S. Food and Drug Administration has added licenses of GastroPlus™ for ...
Dr. Viera Lukacova, team leader for Simulation Technologies at Simulations Plus, said, "Version 8.5 is the result of many months of work by a number of our scientists and staff to add new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results